Metropolis Healthcare Ltd
METROPOLISMetropolis Healthcare Ltd
METROPOLIS
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 77.78 | 9.69 | 0.19% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.93 | 6.39 | 0.52% |
Forecast & Ratings
Detailed Forecast from 14 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Metropolis Healthcare is a medical laboratory operator
Peers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Global Health Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 493.95 | 570.31 | 654.93 | 769.39 | 864.98 | 1,010.04 | 1,261.96 | 1,163.43 | 1,216.83 | 1,252.49 | ||||||||||
Raw Materials | 124.59 | 135.10 | 145.90 | 173.51 | 204.14 | 252.16 | 276.02 | 253.26 | 242.57 | 945.52 | ||||||||||
| Power & Fuel Cost | 8.06 | 9.12 | 9.99 | 11.00 | 12.49 | 12.00 | 14.73 | 14.43 | 16.20 | |||||||||||
| Employee Cost | 108.18 | 127.70 | 147.37 | 176.21 | 190.16 | 198.64 | 233.17 | 252.73 | 275.78 | |||||||||||
| Selling & Administrative Expenses | 87.03 | 101.29 | 90.92 | 106.87 | 165.77 | 185.28 | 311.76 | 289.77 | 307.81 | |||||||||||
| Operating & Other expenses | 20.32 | 18.01 | 74.51 | 91.07 | 71.76 | 60.12 | 44.68 | 44.67 | 77.42 | |||||||||||
EBITDA | 145.77 | 179.09 | 186.24 | 210.73 | 220.66 | 301.84 | 381.60 | 308.57 | 297.05 | 306.97 | ||||||||||
| Depreciation/Amortization | 16.64 | 17.23 | 19.02 | 20.07 | 39.27 | 45.94 | 63.22 | 89.22 | 94.47 | 99.19 | ||||||||||
| PBIT | 129.13 | 161.86 | 167.22 | 190.66 | 181.39 | 255.90 | 318.38 | 219.35 | 202.58 | 207.78 | ||||||||||
| Interest & Other Items | 1.60 | 1.94 | 3.54 | 4.12 | 12.65 | 11.56 | 25.02 | 31.85 | 27.89 | 21.21 | ||||||||||
| PBT | 127.53 | 159.92 | 163.68 | 186.54 | 168.74 | 244.34 | 293.36 | 187.50 | 174.69 | 186.57 | ||||||||||
| Taxes & Other Items | 50.73 | 58.26 | 59.45 | 66.40 | 41.41 | 61.22 | 79.16 | 44.62 | 46.87 | 49.61 | ||||||||||
| Net Income | 76.80 | 101.66 | 104.23 | 120.14 | 127.33 | 183.12 | 214.20 | 142.88 | 127.82 | 136.96 | ||||||||||
| EPS | 15.22 | 20.48 | 21.00 | 24.07 | 25.26 | 36.00 | 41.88 | 27.91 | 24.96 | 26.74 | ||||||||||
| DPS | 15.46 | 10.07 | 0.00 | 13.26 | 8.00 | 8.00 | 8.00 | 8.00 | 4.00 | 4.00 | ||||||||||
| Payout ratio | 1.02 | 0.49 | 0.00 | 0.55 | 0.32 | 0.22 | 0.19 | 0.29 | 0.16 | 0.15 |
Company Updates
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Metropolis Healthcare Ltd | 83.34 | 9.69 | 0.19% |
| Apollo Hospitals Enterprise Ltd | 109.72 | 13.47 | 0.23% |
| Max Healthcare Institute Ltd | 79.63 | 10.02 | 0.17% |
| Fortis Healthcare Ltd | 67.92 | 4.75 | 0.19% |
Price Comparison
Compare METROPOLIS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.17%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 2.37%
Top 5 Mutual Funds holding Metropolis Healthcare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
HDFC Focused 30 Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.2821% | Percentage of the fund’s portfolio invested in the stock 2.53% | Change in the portfolio weight of the stock over the last 3 months 0.19% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 13/36 (+3) |
HDFC Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.2323% | Percentage of the fund’s portfolio invested in the stock 0.56% | Change in the portfolio weight of the stock over the last 3 months 0.14% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 41/57 (+12) |
Nippon India Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.2782% | Percentage of the fund’s portfolio invested in the stock 0.40% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 149/226 (-3) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Trend In Dividends
METROPOLIS has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Current dividend yield is 0.19%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.92 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateNov 17, 2023
Dividend/Share
₹4.00
Ex DateEx Date
Nov 17, 2023
Cash Dividend
Ex DateEx DateFeb 23, 2023
Dividend/Share
₹8.00
Ex DateEx Date
Feb 23, 2023
Cash Dividend
Ex DateEx DateFeb 21, 2022
Dividend/Share
₹8.00
Ex DateEx Date
Feb 21, 2022
Cash Dividend
Ex DateEx DateFeb 17, 2021
Dividend/Share
₹8.00
Ex DateEx Date
Feb 17, 2021
Cash Dividend
Ex DateEx DateFeb 13, 2020
Dividend/Share
₹8.00
Ex DateEx Date
Feb 13, 2020
Net profit of Metropolis Healthcare rose 31.77% to Rs 37.95 crore in the quarter ended June 2024 as against Rs 28.80 crore during the previous quarter ended June 2023. Sales rose 13.09% to Rs 313.36 crore in the quarter ended June 2024 as against Rs 277.09 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales313.36277.09 13 OPM %25.1522.71 - PBDT76.6260.01 28 PBT51.0839.19 30 NP37.9528.80 32 Powered by Capital Market - Live
Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 10 August 2024.Powered by Capital Market - Live
Metropolis Healthcare announced that the 24th Annual General Meeting (AGM) of the company will be held on 21 August 2024.Powered by Capital Market - Live
Metropolis Healthcare has allotted 12,823 equity shares under the MHL- Restrictive Stock Unit Plan, 2020.Powered by Capital Market - Live
Metropolis Healthcare revenue climbs 13% YoY Q1
Indians More Willing to Spend on Health Post-Covid; Demand for Wellness Packages Up: Metropolis Healthcare CEO - News18
Stocks To Watch: TCS, Dr. Reddy’s Labs, Wipro, Phoenix Mills, Metropolis Healthcare, CAMS, Trident
Trade setup for Monday: 15 things to know before opening bell
Metropolis Healthcare Gets Rs 24.46 Crore Income Tax Demand
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 9.6%, vs industry avg of 10.16%
Decreasing Market Share
Over the last 5 years, market share decreased from 2.09% to 1.97%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 1.25%, vs industry avg of 42.82%